drugset / Trial / NCT04755595

Combination Facial Aesthetic Treatment in Millennials

NCT04755595 ↗

NaSingle-groupOpen-labelTreatment

Summary

With 63% of consumers willing to consider investing in facial aesthetics and 73% of consumers worldwide expecting to invest in aesthetic treatments in the upcoming year, it is imperative to explore patient satisfaction and psychosocial impact of a multimodal aesthetic treatment in a millennial cohort. The investigators hypothesize that a combination approach to facial aesthetic treatment in a millennial cohort will result in increased patient-reported satisfaction in multiple areas, including perception of aging concerns and quality of life.

Timeline

Start
2021-03-09
Primary completion
2021-05-19
Completion
2021-05-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Botox Cosmetic Protein / enzyme biologic — —

Indications

No indication recorded.